Evidence map›Paper›PMID 11160665›Full record

ArticleJournal of virology2001

Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.

J L Foster, R P Molina, T Luo, V K Arora, Y Huang, D D Ho, J V Garcia

Abstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mechanisms of HIV-1 Nef function and intracellular signaling.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Review
  9. Article
  10. Article
  11. HIV-1 Nef: at the crossroads.Retrovirology · 2008
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J L FosterDepartment of Internal Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA.
R P Molina
T Luo
V K Arora
Y Huang
D D Ho
J V Garcia

Funding

VIRAL AND IMMUNE CONSEQUENCES OF EARLY HIV1 THERAPYU01AI041534 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI MARKOWITZ, MARTIN H · 1997 to 2006
$10.1M
NEF FUNCTIONR01AI033331 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA-MARTINEZ, J. VICTOR · 1994 to 2010
$4.4M
CORE--VIROLOGYP30AI042848 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HO, DAVID D · 1998 to 2002
$4.3M
HIV1/SIV DYNAMICS AND LYMPHOCYTE TURNOVERR01AI040387 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI HO, DAVID D · 1996 to 2000
$519k
CANCER IMMUNOLOGY TRAINING PROGRAMT32CA009082 · NCI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI FORMAN, JAMES M · 1985 to 2000
$313k
NEF ASSOCIATED KINASER21GM060805 · NIGMS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI GARCIA-MARTINEZ, J. VICTOR · 1999 to 2000
$109k
NCI NIH HHS T32 CA009082NIAID NIH HHS AI33331NIAID NIH HHS AI40387NIAID NIH HHS P30 AI042848NIAID NIH HHS R01 AI033331NIAID NIH HHS U01 AI041534NIGMS NIH HHS GM60805
6 · The paper itself

Abstract

We have characterized the functional integrity of seven primary Nef isolates: five from a long-term nonprogressing human immunodeficiency virus (HIV)-infected individual and one each from two patients with AIDS. One of the seven Nefs was defective for CD4 downregulation, two others were defective for PAK-2 activation, and one Nef was defective for PAK-2 activation and major histocompatibility complex (MHC) class I downregulation. Five of the Nefs were tested and found to be functional for the enhancement of virus particle infectivity. The structural basis for each of the functional defects has been analyzed by constructing a consensus nef, followed by mutational analysis of the variant amino acid residues. Mutations A29V and F193I were deleterious to CD4 downregulation and PAK-2 activation, respectively, while S189R rendered Nef defective for both MHC class I downregulation and PAK-2 activation. A search of the literature identified HIVs from five patients with Nefs predominantly mutated at F193 and from one patient with Nefs predominantly mutated at A29. A29 is highly conserved in all HIV subtypes except for subtype E. F193 is conserved in subtype B (and possibly in the closely related subtype D), but none of the other HIV group M subtypes. Our results suggest that functional distinctions may exist between HIV subtypes.

Indexed as

Genetic VariationAcquired Immunodeficiency SyndromeAmino Acid SequenceCell LineGene Products, nefGenes, nefHIV-1HIV InfectionsHIV Long-Term SurvivorsHumansMolecular Sequence DataMutagenesis, Site-Directednef Gene Products, Human Immunodeficiency VirusPlasmidsProtein Serine-Threonine KinasesTransfectionGene Products, nefnef Gene Products, Human Immunodeficiency VirusProtein Serine-Threonine Kinases

Identifiers

PMID11160665
PMCPMC114076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.